Bank of Montreal
VIVO

Bank of Montreal’s Meridian Bioscience Inc VIVO Stock Holding History

Bank of Montreal’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,821
Closed -$227K – 4470
2022
Q4 		$227K Buy
6,821
+662
+11% +$21.3K ﹤0.01% 3084
2022
Q3 		$206 Sell
6,159
-280
-4% -$9.07K ﹤0.01% 3194
2022
Q2 		$202 Sell
6,439
-7,705
-54% -$208K ﹤0.01% 3270
2022
Q1 		$383K Buy
14,144
+955
+7% +$22.7K ﹤0.01% 3030
2021
Q4 		$268K Sell
13,189
-6,710
-34% -$129K ﹤0.01% 2797
2021
Q3 		$387K Sell
19,899
-333
-2% -$6.64K ﹤0.01% 3013
2021
Q2 		$457K Buy
20,232
+5,774
+40% +$122K ﹤0.01% 2870
2021
Q1 		$372K Buy
14,458
+1,941
+16% +$46.2K ﹤0.01% 2820
2020
Q4 		$275K Buy
12,517
+7,029
+128% +$131K ﹤0.01% 3043
2020
Q3 		$100K Sell
5,488
-1,412
-20% -$27.4K ﹤0.01% 3075
2020
Q2 		$172K Sell
6,900
-7,936
-53% -$115K ﹤0.01% 2812
2020
Q1 		$129K Sell
14,836
-321,327
-96% -$2.71M ﹤0.01% 2504
2019
Q4 		$3.29M Buy
336,163
+133,809
+66% +$1.26M ﹤0.01% 1602
2019
Q3 		$1.92M Buy
202,354
+49,395
+32% +$521K ﹤0.01% 1716
2019
Q2 		$1.82M Sell
152,959
-2,497
-2% -$30.1K ﹤0.01% 1751
2019
Q1 		$2.74M Buy
155,456
+74,357
+92% +$1.24M ﹤0.01% 1495
2018
Q4 		$1.41M Buy
81,099
+10,253
+14% +$175K ﹤0.01% 1715
2018
Q3 		$1.05M Buy
70,846
+17,378
+33% +$269K ﹤0.01% 1976
2018
Q2 		$850K Buy
53,468
+47,750
+835% +$712K ﹤0.01% 2086
2018
Q1 		$82K Buy
5,718
+3,981
+229% +$58.9K ﹤0.01% 3045
2017
Q4 		$25K Sell
1,737
-1,959
-53% -$28.7K ﹤0.01% 3519
2017
Q3 		$53K Sell
3,696
-8,584
-70% -$123K ﹤0.01% 3207
2017
Q2 		$193K Hold
12,280
– – ﹤0.01% 2670
2017
Q1 		$169K Buy
12,280
+11,594
+1,690% +$162K ﹤0.01% 2562
2016
Q4 		$12K Sell
686
-1,726
-72% -$30.3K ﹤0.01% 3544
2016
Q3 		$46K Sell
2,412
-18
-0.7% -$352 ﹤0.01% 3079
2016
Q2 		$47K Buy
2,430
+18
+0.7% +$353 ﹤0.01% 3085
2016
Q1 		$50K Sell
2,412
-156
-6% -$3.07K ﹤0.01% 3049
2015
Q4 		$52K Buy
2,568
+1,342
+109% +$25.7K ﹤0.01% 3028
2015
Q3 		$21K Buy
1,226
+702
+134% +$12.8K ﹤0.01% 3240
2015
Q2 		$10K Sell
524
-697
-57% -$12.9K ﹤0.01% 3501
2015
Q1 		$23K Buy
1,221
+122
+11% +$2.26K ﹤0.01% 3227
2014
Q4 		$18K Buy
1,099
+146
+15% +$2.5K ﹤0.01% 3391
2014
Q3 		$17K Sell
953
-1,126
-54% -$22.1K ﹤0.01% 3523
2014
Q2 		$43K Buy
2,079
+784
+61% +$16.1K ﹤0.01% 3262
2014
Q1 		$28K Sell
1,295
-1,123
-46% -$25.7K ﹤0.01% 3369
2013
Q4 		$64K Buy
2,418
+1,083
+81% +$26.6K ﹤0.01% 2751
2013
Q3 		$32K Sell
1,335
-4,605
-78% -$108K ﹤0.01% 3022
2013
Q2 		$127K Buy
+5,940
New +$128K ﹤0.01% 2348

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of Montreal's VIVO Position: Q1 2023 in Review

Bank of Montreal sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 6,821 shares — an estimated $227K sold.

Bank of Montreal first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $3.29M in Q4 2019. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Bank of Montreal reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 6,821 Meridian Bioscience Inc shares in Q1 2023, an estimated $227K.
  • Bank of Montreal first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Bank of Montreal's Meridian Bioscience Inc position peaked at $3.29M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.